Mulders PF - Search Results

1

A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients.

Bleumer I, Knuth A, Oosterwijk E, Hofmann R, Varga Z, Lamers C, Kruit W, Melchior S, Mala C, Ullrich S, De Mulder P, Mulders PF, Beck J. Bleumer I, et al. Among authors: mulders pf. Br J Cancer. 2004 Mar 8;90(5):985-90. doi: 10.1038/sj.bjc.6601617. Br J Cancer. 2004. PMID: 14997194 Free PMC article. Clinical Trial.

2

Analysis of prognostic factors in disseminated prostatic cancer. An update. Dutch Southeastern Urological Cooperative Group.

Mulders PF, Dijkman GA, Fernandez del Moral P, Theeuwes AG, Debruyne FM. Mulders PF, et al. Cancer. 1990 Jun 15;65(12):2758-61. doi: 10.1002/1097-0142(19900615)65:12<2758::aid-cncr2820651225>3.0.co;2-6. Cancer. 1990. PMID: 2187588 Clinical Trial.

3

The importance of prognostic factors in the individual treatment of patients with disseminated germ cell tumours.

Mulders PF, Oosterhof GO, Boetes C, de Mulder PH, Theeuwes AG, Debruyne FM. Mulders PF, et al. Br J Urol. 1990 Oct;66(4):425-9. doi: 10.1111/j.1464-410x.1990.tb14967.x. Br J Urol. 1990. PMID: 2224438

4

Prognostic factors in pTa-pT1 superficial bladder tumours treated with intravesical instillations. The Dutch South-Eastern Urological Collaborative Group.

Mulders PF, Meyden AP, Doesburg WH, Oosterhof GO, Debruyne FM. Mulders PF, et al. Br J Urol. 1994 Apr;73(4):403-8. doi: 10.1111/j.1464-410x.1994.tb07604.x. Br J Urol. 1994. PMID: 8199828 Clinical Trial.

5

Prognostic value of karyometric and clinical characteristics in renal cell carcinoma. Quantitative assessment of tumor heterogeneity.

van der Poel HG, Mulders PF, Oosterhof GO, Schaafsma HE, Hendriks JC, Schalken JA, Debruyne FM. van der Poel HG, et al. Among authors: mulders pf. Cancer. 1993 Nov 1;72(9):2667-74. doi: 10.1002/1097-0142(19931101)72:9<2667::aid-cncr2820720924>3.0.co;2-0. Cancer. 1993. PMID: 8402488

6

The role of adjuvant immunotherapy in renal cell carcinoma.

Mulders PF, De Mulder PH. Mulders PF, et al. Curr Urol Rep. 2002 Feb;3(1):44-9. doi: 10.1007/s11934-002-0010-y. Curr Urol Rep. 2002. PMID: 12084219 Review.

7

Vaccination of patients with metastatic renal cell carcinoma with autologous dendritic cells pulsed with autologous tumor antigens in combination with interleukin-2: a phase 1 study.

Oosterwijk-Wakka JC, Tiemessen DM, Bleumer I, de Vries IJ, Jongmans W, Adema GJ, Debruyne FM, de Mulder PH, Oosterwijk E, Mulders PF. Oosterwijk-Wakka JC, et al. Among authors: mulders pf. J Immunother. 2002 Nov-Dec;25(6):500-8. doi: 10.1097/00002371-200211000-00006. J Immunother. 2002. PMID: 12439347 Clinical Trial.

8

Correspondence re: Y. S. Haviv, J. L. Blackwell, A. Kanerva, P. Nagi, V. Krasnykh, I. Dmitriev, M. Wang, S. Naito, X. Lei, A. Hemminki, D. Carey, and D. T. Curiel, Adenoviral gene therapy for renal cancer requires retargeting to alternative cellular receptors. Cancer Res., 62: 4273-4281, 2002.

Jongmans W, Tiemessen DM, Oosterwijk E, Mulders PF. Jongmans W, et al. Among authors: mulders pf. Cancer Res. 2003 Apr 15;63(8):1994-5. Cancer Res. 2003. PMID: 12702594 No abstract available.

9

Immunotherapy for renal cell carcinoma.

Bleumer I, Oosterwijk E, De Mulder P, Mulders PF. Bleumer I, et al. Among authors: mulders pf. Eur Urol. 2003 Jul;44(1):65-75. doi: 10.1016/s0302-2838(03)00191-x. Eur Urol. 2003. PMID: 12814677 Review.

10

Targeting of adenovirus to human renal cell carcinoma cells.

Jongmans W, van den Oudenalder K, Tiemessen DM, Molkenboer J, Willemsen R, Mulders PF, Oosterwijk E. Jongmans W, et al. Among authors: mulders pf. Urology. 2003 Sep;62(3):559-65. doi: 10.1016/s0090-4295(03)00378-9. Urology. 2003. PMID: 12946777

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

250 results

Search Page

Filters